Innovating Works
SC1-HCO-17-2017
SC1-HCO-17-2017: Support for large scale uptake of Digital Innovation for Active and Healthy Ageing
Specific Challenge:Several activities on scaling up of digital innovation for active and healthy ageing are currently pursued by the Commission in cooperation with a large number of different stakeholder groups and partner organisations. A coordination and support action is needed to promote the effective uptake and impact of these activities and to leverage additional investments by mobilising other national and regional programmes together with private investments.
Sólo fondo perdido 0 €
Europeo
Esta convocatoria está cerrada Esta línea ya está cerrada por lo que no puedes aplicar. Cerró el pasado día 31-01-2017.
Se espera una próxima convocatoria para esta ayuda, aún no está clara la fecha exacta de inicio de convocatoria.
Por suerte, hemos conseguido la lista de proyectos financiados!
Presentación: Consorcio Consorcio: Esta ayuda está diseñada para aplicar a ella en formato consorcio.
Número mínimo de participantes.
Esta ayuda financia Proyectos: Objetivo del proyecto:

Specific Challenge:Several activities on scaling up of digital innovation for active and healthy ageing are currently pursued by the Commission in cooperation with a large number of different stakeholder groups and partner organisations. A coordination and support action is needed to promote the effective uptake and impact of these activities and to leverage additional investments by mobilising other national and regional programmes together with private investments.


Scope:Proposals should provide support to administration, external communication and coordination of the stakeholder groups and partners engaged in the development and implementation of the following three activities:

(i) Coordinated support to innovators, buyers / industry integrators, distribution networks and investors to facilitate successful introduction of innovations to the market: The work should maximise EU-wide and global market uptake of innovative digital solutions developed by EU funded projects in the area of active and healthy ageing. Under the guidance of the European Commission, this support action will develop and execute an "Innovation to Market (I2M)" plan... ver más

Specific Challenge:Several activities on scaling up of digital innovation for active and healthy ageing are currently pursued by the Commission in cooperation with a large number of different stakeholder groups and partner organisations. A coordination and support action is needed to promote the effective uptake and impact of these activities and to leverage additional investments by mobilising other national and regional programmes together with private investments.


Scope:Proposals should provide support to administration, external communication and coordination of the stakeholder groups and partners engaged in the development and implementation of the following three activities:

(i) Coordinated support to innovators, buyers / industry integrators, distribution networks and investors to facilitate successful introduction of innovations to the market: The work should maximise EU-wide and global market uptake of innovative digital solutions developed by EU funded projects in the area of active and healthy ageing. Under the guidance of the European Commission, this support action will develop and execute an "Innovation to Market (I2M)" plan of activities that will enable early cross-border engagement across the EU and internationally. The I2M plan will build on existing European initiatives and networks in this area, and ensure that project innovators leverage these networks and identified market needs together and link to organisations and access to finance facilities that work with start-ups and SMEs.

(ii) Coordinated support to the further development of a European "Blueprint" on Digital Innovation for Active and Healthy Ageing: The work should include an updated roadmap[1] setting out the most important ICT enabling technologies (building on technology roadmaps from major EU ICT initiatives behind them) which will impact on key user scenarios in active and healthy ageing in the short, medium and long terms. The support action will enhance the European policy vision and strengthen the community of public and private stakeholders actively supporting it.

The support action will also facilitate the cooperation of key stakeholders, such as industry, financial institutions, investors, insurers, the research community and public authorities (health and care organisations) that are committed to innovate at large scale, to mobilise private investments and identify market opportunities as well as threats to Europe's digital health and care delivery and silver economy sectors.

(iii) Coordinated support to the activities of the EIP on AHA: An important component of the policy vision on digital innovation for active and healthy ageing is the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA). Through its strategic implementation plan (SIP) and subsequent Scaling-up Strategy, the EIP on AHA partners have identified a number of priority action areas. Stakeholder action groups have developed action plans for the period of 2016-2018 for implementing innovative services for the ageing population. In its third call launched in 2016, Reference Sites have also committed to undertake investments in scaling up innovation for active and healthy ageing. Since 2015 the EIP on AHA has developed a Monitoring and Assessment Framework (MAFEIP) that is designed to capture the impact of different EIP on AHA activities. Under the guidance of the European Commission and in collaboration with the EIP on AHA Governance Board, the coordination and support action will provide support for the development and execution of EIP on AHA Action Group plans 2018-2020, support Reference Sites initiatives to scale up innovation across the EU, manage the MAFEIP tool to capture the impact of the EIP on AHA activities, strengthen the external communication of the EIP on AHA vis a vis investors, industrial players, start-ups / SMEs and public authorities. The coordination and support action will use the MAFEIP tool to produce outputs illustrating the impact of the EIP on AHA activities on a regular (annual) cycle.

The coordination and support action should provide centralised administrative support, state of the art external communications and operational coordination based on a strategy to support the new I2M plan, the policy vision on digital innovation for active and healthy ageing, and the EIP on AHA.

The coordination and support action will lead to extended reach to (and continued support by) external stakeholders, including industry players, the investment community, health and care organisations, national and regional public authorities and governments. It will seek to establish the foundations for the self-sustainability of the EIP on AHA organisation (beyond 2020).

The coordination and support action will identify synergies, establish communication links and build on relevant research and innovation activities of H2020 and other European Union, national and international programmes targeting Active and Healthy Ageing. This way it may also relate to the WHO's Active and Healthy Ageing[2] strategy by contributing to more effective and personalized health care services to the ageing population.

The Commission considers that proposals requesting a contribution from the EU up to EUR 2 million would allow this specific challenge to be addressed appropriately with an anticipated duration until 31 December 2020. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.


Expected Impact:Proposals should present quantitative and qualitative indicators to capture the impact of the policy actions in the following areas:

Increased uptake of digital solutions for Active and Healthy Ageing, including results from relevant Horizon 2020 research and innovation activities. Accelerated progress on favourable framework conditions to scaling-up digital innovation for active and healthy ageing across the EU. Increased levels of participation by external stakeholders in the development and execution of the policy activities as described above (policy vision, I2M and EIP on AHA). Contribution of the policy activities to i. The Quality of Life of the EU population, ii. The Sustainability of Health and Care delivery and iii. Economic growth and job-creation in the EU. Increased levels of investment by public authorities and private investors in digital innovation for health and active ageing that result from policy activities. Enhanced communication with external stakeholders and coordination of activities within the EIP on AHA and between the EIP on AHA and other new or existing policy activities. Enhanced synergies with other relevant CSAs and Research & Innovation projects financed by the European Commission.
[1]See existing roadmap at http://www.aaliance.eu

[2]http://www.who.int/mediacentre/news/releases/2015/older-persons-day/en/

ver menos

Temáticas Obligatorias del proyecto: Temática principal:

Características del consorcio

Ámbito Europeo : La ayuda es de ámbito europeo, puede aplicar a esta linea cualquier empresa que forme parte de la Comunidad Europea.
Tipo y tamaño de organizaciones: El diseño de consorcio necesario para la tramitación de esta ayuda necesita de:

Características del Proyecto

Requisitos de diseño: Duración:
Requisitos técnicos: Specific Challenge:Several activities on scaling up of digital innovation for active and healthy ageing are currently pursued by the Commission in cooperation with a large number of different stakeholder groups and partner organisations. A coordination and support action is needed to promote the effective uptake and impact of these activities and to leverage additional investments by mobilising other national and regional programmes together with private investments. Specific Challenge:Several activities on scaling up of digital innovation for active and healthy ageing are currently pursued by the Commission in cooperation with a large number of different stakeholder groups and partner organisations. A coordination and support action is needed to promote the effective uptake and impact of these activities and to leverage additional investments by mobilising other national and regional programmes together with private investments.
¿Quieres ejemplos? Puedes consultar aquí los últimos proyectos conocidos financiados por esta línea, sus tecnologías, sus presupuestos y sus compañías.
Capítulos financiables: Los capítulos de gastos financiables para esta línea son:
Personnel costs.
Los costes de personal subvencionables cubren las horas de trabajo efectivo de las personas directamente dedicadas a la ejecución de la acción. Los propietarios de pequeñas y medianas empresas que no perciban salario y otras personas físicas que no perciban salario podrán imputar los costes de personal sobre la base de una escala de costes unitarios
Purchase costs.
Los otros costes directos se dividen en los siguientes apartados: Viajes, amortizaciones, equipamiento y otros bienes y servicios. Se financia la amortización de equipos, permitiendo incluir la amortización de equipos adquiridos antes del proyecto si se registra durante su ejecución. En el apartado de otros bienes y servicios se incluyen los diferentes bienes y servicios comprados por los beneficiarios a proveedores externos para poder llevar a cabo sus tareas
Subcontracting costs.
La subcontratación en ayudas europeas no debe tratarse del core de actividades de I+D del proyecto. El contratista debe ser seleccionado por el beneficiario de acuerdo con el principio de mejor relación calidad-precio bajo las condiciones de transparencia e igualdad (en ningún caso consistirá en solicitar menos de 3 ofertas). En el caso de entidades públicas, para la subcontratación se deberán de seguir las leyes que rijan en el país al que pertenezca el contratante
Amortizaciones.
Activos.
Otros Gastos.
Madurez tecnológica: La tramitación de esta ayuda requiere de un nivel tecnológico mínimo en el proyecto de TRL 5:. Los elementos básicos de la innovación son integrados de manera que la configuración final es similar a su aplicación final, es decir que está listo para ser usado en la simulación de un entorno real. Se mejoran los modelos tanto técnicos como económicos del diseño inicial, se ha identificado adicionalmente aspectos de seguridad, limitaciones ambiéntales y/o regulatorios entre otros. + info.
TRL esperado:

Características de la financiación

Intensidad de la ayuda: Sólo fondo perdido + info
Fondo perdido:
0% 25% 50% 75% 100%
Please read carefully all provisions below before the preparation of your application.
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects. See the information in the Online Manual.
 
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme.
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
 
Evaluation
3.1  Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme.
3.2 Submission and evaluation process: Guide to the submission and evaluation process
      
Indicative timetable for evaluation and grant agreement:
Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
 
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
Coordination and Support Action:
Specifi...
Please read carefully all provisions below before the preparation of your application.
List of countries and applicable rules for funding: described in part A of the General Annexes of the General Work Programme.
Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects. See the information in the Online Manual.
 
Eligibility and admissibility conditions: described in part B and C of the General Annexes of the General Work Programme.
Proposal page limits and layout: Please refer to Part B of the standard proposal template.
 
Evaluation
3.1  Evaluation criteria and procedure, scoring and threshold: described in part H of the General Annexes of the General Work Programme.
3.2 Submission and evaluation process: Guide to the submission and evaluation process
      
Indicative timetable for evaluation and grant agreement:
Information on the outcome of single-stage evaluation: maximum 5 months from the deadline for submission.
Signature of grant agreements: maximum 8 months from the deadline for submission.
 
Provisions, proposal templates and evaluation forms for the type(s) of action(s) under this topic:
Coordination and Support Action:
Specific provisions and funding rates
Proposal templates are available after entering the submission tool below.
Standard evaluation form
H2020 General MGA -Multi-Beneficiary
Annotated Grant Agreement
 
Additional provisions:
Horizon 2020 budget flexibility
Classified information
 
Open access must be granted to all scientific publications resulting from Horizon 2020 actions. Where relevant, proposals should also provide information on how the participants will manage the research data generated and/or collected during the project, such as details on what types of data the project will generate, whether and how this data will be exploited or made accessible for verification and re-use, and how it will be curated and preserved.
Open access to research data
The Open Research Data Pilot has been extended to cover all Horizon 2020 topics for which the submission is opened on 26 July 2016 or later. Projects funded under this topic will therefore by default provide open access to the research data they generate, except if they decide to opt-out under the conditions described in annex L of the Work Programme. Projects can opt-out at any stage, that is both before and after the grant signature.
Note that the evaluation phase proposals will not be evaluated more favourably because they plan to open or share their data, and will not be penalised for opting out.
Open research data sharing applies to the data needed to validate the results presented in scientific publications. Additionally, projects can choose to make other data available open access and need to describe their approach in a Data Management Plan.
Projects need to create a Data Management Plan (DMP), except if they opt-out of making their research data open access. A first version of the DMP must be provided as an early deliverable within six months of the project and should be updated during the project as appropriate. The Commission already provides guidance documents, including a template for DMPs.- Eligibility of costs: costs related to data management and data sharing are eligible for reimbursement during the project duration. Eligibility of costs: costs related to data management and data sharing are eligible for reimbursement during the project duration.
The legal requirements for projects participating in this pilot are in the article 29.3 of the Model Grant Agreement.
 
Additional documents:
H2020 Work Programme 2016-17: Introduction
H2020 Work Programme 2016-17: Health, demographic change and wellbeing
H2020 Work Programme 2016-17: Dissemination, Exploitation and Evaluation
H2020 Work Programme 2016-17: General Annexes
Legal basis: Horizon 2020 - Regulation of Establishment
Legal basis: Horizon 2020 Rules for Participation
Legal basis: Horizon 2020 Specific Programme
 
Garantías:
No exige Garantías
No existen condiciones financieras para el beneficiario.

Información adicional de la convocatoria

Efecto incentivador: Esta ayuda tiene efecto incentivador, por lo que el proyecto no puede haberse iniciado antes de la presentación de la solicitud de ayuda. + info.
Respuesta Organismo: Se calcula que aproximadamente, la respuesta del organismo una vez tramitada la ayuda es de:
Meses de respuesta:
Muy Competitiva:
No Competitiva Competitiva Muy Competitiva
No conocemos el presupuesto total de la línea
Minimis: Esta línea de financiación NO considera una “ayuda de minimis”. Puedes consultar la normativa aquí.

Otras ventajas

Sello PYME: Tramitar esta ayuda con éxito permite conseguir el sello de calidad de “sello pyme innovadora”. Que permite ciertas ventajas fiscales.
H2020-SC1-2016-2017 Support for large scale uptake of Digital Innovation for Active and Healthy Ageing Specific Challenge:Several activities on scaling up of digital innovation for active and healthy ageing are currently pursued by the Commiss...
Sin info.
SC1-HCO-01-2018-2019-2020 Actions in support of the International Consortium for Personalised Medicine
en consorcio:
Cerrada hace 4 años | Próxima convocatoria prevista para el mes de
SC1-HCO-03-2020 Bridging the divide in health research and innovation – boosting return on investment
en consorcio: Specific Challenge:The Innovation Union Scoreboard reveals significant disparities in terms of research and innovation performance among the...
Cerrada hace 4 años | Próxima convocatoria prevista para el mes de
SC1-HCO-17-2020 Coordinating and supporting research on the human microbiome in Europe and beyond
en consorcio: Specific Challenge:Integration and application of metagenomics data from the human microbiome has shown large potential for personalised med...
Cerrada hace 4 años | Próxima convocatoria prevista para el mes de
SC1-HCO-07-2020 ERA-NET to support the Joint Programming Initiative on Antimicrobial resistance (JPIAMR)
en consorcio: Specific Challenge:Antimicrobial resistance (AMR) is a serious challenge that has reached alarming levels in the EU and globally. There is a...
Cerrada hace 4 años | Próxima convocatoria prevista para el mes de
SC1-HCO-19-2020 Reliable and accessible information on cell and gene-based therapies
en consorcio: Specific Challenge:Cell and gene-based therapies have the potential to treat many debilitating diseases and conditions. However, the pace of...
Cerrada hace 4 años | Próxima convocatoria prevista para el mes de